VINZENZ GRUPPE
     
 

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection.

Muir, Andrew J, Arora, Sanjeev, Everson, Gregory, Flisiak, Robert, George, Jacob, Ghalib, Reem, Gordon, Stuart C, Gray, Todd, Greenbloom, Susan, Hassanein, Tarek, Hillson, Jan, Horga, Maria Arantxa, Jacobson, Ira M, Jeffers, Lennox, Kowdley, Kris V, Lawitz, Eric, Lueth, Stefan, Rodriguez-Torres, Maribel, Rustgi, Vinod, Shemanski, Lynn, Shiffman, Mitchell L, Srinivasan, Subasree, Vargas, Hugo E, Vierling, John M, Xu, Dong, Lopez-Talavera, Juan C and Zeuzem, Stefan (2014) A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection. Journal of hepatology, 61 (6). pp. 1238-46. ISSN 1600-0641

Full text not available from this repository.
Item Type: Article
Divisions: Ordensklinikum Linz Elisabethinen > Interne 4 - Gastroenterologie & Hepatologie, Stoffwechsel & Ernährungsmedizin, Endokrinologie
Depositing User: Prof. Dr. Rainer Schöfl
Date Deposited: 29 Oct 2019 12:32
Last Modified: 17 Feb 2025 09:33
URI: https://eprints.vinzenzgruppe.at/id/eprint/8782
Edit Item Edit Item